SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-144986
Filing Date
2022-05-09
Accepted
2022-05-09 16:09:49
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d300508d8k.htm   iXBRL 8-K 25899
2 EX-99.1 d300508dex991.htm EX-99.1 54328
6 GRAPHIC g300508g95s42.jpg GRAPHIC 9098
  Complete submission text file 0001193125-22-144986.txt   221603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220509.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220509_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220509_pre.xml EX-101.PRE 11287
8 EXTRACTED XBRL INSTANCE DOCUMENT d300508d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 22904995
SIC: 2834 Pharmaceutical Preparations